Well Med Clinical Research San Antonio, TX - 78229

Well Med Clinical Research is categorized under Medical Centers in San Antonio, TX and active since 1990.

Well Med Clinical Research was established in 1990, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Medical Centers business, which does work in the B2C market, and is classified as a Medical Centers, under code number 6214930 by the NAICS.

If you are seeking more information, feel free to contact Debbie Delarosa, Manager at the company’s branch by writing to 7622 Louis Pasteur Drive # 201, San Antonio, Texas TX 78229 or by phoning (210) 615-4460. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Well Med Clinical Research
Contact Person: Debbie Delarosa, Manager
Address: 7622 Louis Pasteur Drive # 201, San Antonio, Texas 78229
Phone Number: (210) 615-4460
Website Address: wellmed.net
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 1990
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Medical Centers
SIC Code: 8011
NAICS Code: 6214930
Share This Business:

Well Med Clinical Research was started in 1990 to provide professional Medical Centers under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Debbie Delarosa, Manager for inquiries that concern Well Med Clinical Research by calling the company number (210) 615-4460, as your correspondence is most welcome. Additionally, the physical location of the branch of Well Med Clinical Research can be found at the coordinates 29.50776,-98.57027 as well as the street address 7622 Louis Pasteur Drive # 201 in San Antonio, Texas 78229.

For its online presence, you may visit Well Med Clinical Research’s website at wellmed.net and engage with its social media outlets through on Twitter and on Facebook.